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NecrosisAs the voltage-dependent anion channel (VDAC) forms the interface between mitochondria and the cytosol, its
importance in metabolism is well understood. However, research on VDAC's role in cell death is a rapidly grow-
ing ﬁeld, unfortunately with much confusing and contradictory results. The fact that VDAC plays a role in outer
mitochondrial membrane permeabilization is undeniable, however, the mechanisms behind this remain very
poorly understood. In this review, we will summarize the studies that show evidence of VDAC playing a role
in cell death. To begin,wewill discuss the evidence for and against VDAC's involvement inmitochondrial perme-
ability transition (MPT) and attempt to clarify that VDAC is not an essential component of theMPT pore (MPTP).
Next, we will evaluate the remaining literature on VDAC in cell death which can be divided into three models:
proapoptotic agents escaping through VDAC, VDAC homo- or hetero-oligomerization, or VDAC closure resulting
in outer mitochondrial membrane permeabilization through an unknown pathway. We will then discuss the
growing list of modulators of VDAC activity that have been associated with induction/protection against cell
death. This article is part of a Special Issue entitled: VDAC structure, function, and regulation of mitochondrial
metabolism.
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The mitochondrial voltage-dependent anion channel (VDAC), also
known as mitochondrial porin, is the most abundant protein in the
outer mitochondrial membrane. The VDAC family of proteins consists
of three isoforms from three separate genes (VDAC1, VDAC2, and
VDAC3). As most studies on VDAC using deﬁned isoforms have been
1445K.S. McCommis, C.P. Baines / Biochimica et Biophysica Acta 1818 (2012) 1444–1450performed with VDAC1, the main focus of this review will be on
VDAC1. However, signiﬁcant ﬁndings from the other two isoforms
will be noted. For this review, ‘VDAC’will be used to reference studies
of undeﬁned isoforms.
While it has been established that VDACs regulate the ion and
metabolite ﬂux between mitochondria and cytosol [1–3], most
other properties and even the structure of the channels are still highly
debated and have been the focus of several past reviews [4–8]. Addi-
tionally, up-to-date reviews onVDAC structure, function, and regulation
ofmetabolism can be foundwithin this special issue. The purpose of this
review is to highlight the role of VDAC and its regulators in mitochon-
drial membrane permeabilization and cell death.
2. VDAC and themitochondrial permeability transition pore (MPTP)
Mitochondrial permeability transition (MPT) is the sudden per-
meabilization of the inner mitochondrial membrane in response to a
noxious stimulus such as oxidative stress, Ca2+ overload, hypoxia,
and cytotoxic drugs [9–13]. The degree of permeabilization is fairly
substantial; although not large enough to allow the passage of pro-
teins, solutes and metabolites up to 1.5 kDa in size can now freely
pass across the normally impermeable inner membrane. This includes
protons such that theΔΨm is dissipated uponMPT, thereby inhibiting
ATP synthesis. Moreover, water can nowmove into the mitochondrial
matrix, down its osmotic gradient, causing themitochondrion to swell
and, if left unchecked, rupture completely. MPT appears to play a crit-
ical role in cell death, especially necrosis [14], and has been implicated
in the development and progression of many diseases including ische-
mia/reperfusion injury, muscular dystrophy, Alzheimer's disease, and
cardiotoxicity. MPT is believed to be mediated by opening of the MPT
pore (MPTP), a highly debated, and undeﬁned protein complex
thought to span both the inner and outer mitochondrial membranes
at membrane contact sites. Needless to say, due to the important
role of MPT in disease pathogenesis there has been a concerted effort
to try and elucidate the molecular makeup for the MPTP.
As VDAC is the most abundant protein in the outer mitochondrial
membrane, it has long been considered a candidate for the outer mem-
brane component of theMPTP. It was ﬁrst proposed as anMPTP constit-
uent nearly 20 years ago byMario Zoratti's groupwho put forward that
the electrical conductance properties of VDACwere similar to those de-
scribed for the MPTP [15,16]. Moreover, it was well established that
the MPTP was redox, Ca2+, voltage, adenine nucleotide, and pH sen-
sitive [10–13]— all attributes that applied to VDAC as well. However,
what was strange was how this concept of VDAC as the outer mem-
brane component of the MPTP slowly morphed from hypothesis to
dogma without much in the way of substantiation in between.
As far as experimental data, initial support for a role for VDAC inMPT
came from Crompton's laboratory, which demonstrated that a GST–
CypD fusion proteinwas able to pull downVDAC alongwith the adenine
nucleotide translocase (ANT), another putative MPTP component from
mitochondrial lysates [17]. Reconstitution of this VDAC–ANT–CypD
complex then resulted in a Ca2+-dependent, cyclosporine-sensitive
channel that was reminiscent of the MPTP [17]. Additional supporting
evidence for VDAC's involvement in MPT came from experiments
using putative VDAC inhibitors and anti-VDAC antibodies. Monoclonal
antibodies purported to block VDAC's channel activity were reported
to prevent MPT in isolated mitochondria [18,19]. Yet the speciﬁcity of
these antibodies for VDAC has been cast into doubt [6]. A study by
Cesura et al. also suggested that VDAC1 is the outer membrane compo-
nent of theMPTP as radioactively labeledMPT inhibitor Ro 68-3400was
shown to bind a protein of ~32 kDa, which was identiﬁed as VDAC1 by
mass spectrometry [20]. However, the same group has since demon-
strated that Ro 68-3400 does not in fact bind to any VDAC isoform [21].
Certainly from a biochemical perspective VDAC would not ﬁt very
well into the MPTP paradigm. The “opened” conﬁguration of VDAC is
the most conductive, and shows a signiﬁcant preference for anions,particularly metabolic anions (ATP/ADP) [6]. The “closed” state greatly
diminishes, but does not abolish ﬂux of metabolic anions, and now fa-
vors conductance of cations [22]. If VDAC were part of the MPTP, it
would make sense for VDAC closure to equal MPTP closure. However,
Marco Colombini has demonstrated that closure of VDAC actually in-
creases Ca2+ ﬂux [22], which if anything should actually promote
opening of the MPTP [80]. Indeed, Tikunov et al. [23] utilized G3139,
an 18-mer phosphorothioate blocker of VDAC to cause VDAC closure,
and MPT was accelerated. Moreover, even its closed state, the VDAC
channel is still large enough to pass solutes up to 1.5 kDa in size, i.e.,
the closed state of VDAC is the same as the open state of the MPTP [6].
Using a similar approach to Crompton's initial reconstitution of a
VDAC-containing MPTP, Halestrap's group was only able to pulldown
ANT (and the mitochondrial phosphate carrier as it later turned out),
but not VDAC with GST–CypD [24]. Yet this VDAC-less precipitate was
still capable of generating an MPTP-like channel in liposomes [24].
Genetic studies have most recently been employed to decipher
the role, if any, of VDAC in MPT. Kroemer's group reported that
VDAC-deﬁcient yeast was more resistant to HIV Vpr-induced MPT
[25]. A similar loss of MPT response was observed in response to eth-
anol in ΔVDAC yeast mitochondria [26]. However, the nature of MPT,
both in terms of properties and regulation, appears to be inherently
different in yeast [27], thus making extrapolations to themammalian
system difﬁcult. In this regard, we have observed an intact MPT re-
sponse in isolatedmousemitochondria and cells essentially deﬁcient
for all three VDAC isoforms, suggesting that VDACs are dispensable
for MPT and are not an essential component of the MPTP [28].
Paolo Bernardi's group has also reported a maintained MPT response
in VDAC1−/− [21] and VDAC1/3−/−mitochondria [29]. Thus, in light
of both the nonspeciﬁc VDAC “blocking” agents used in previous
studies and the more recent ﬁndings of maintained MPT responses
in VDAC-deﬁcient null mitochondria, we must conclude that VDAC
is not an essential component of the MPTP. We found that mitochon-
dria and cells lacking VDAC have an exacerbated MPT and death re-
sponse [28], suggesting that if anything VDAC appears to protect
against, rather than contribute to, MPTP. Consistent with this con-
cept, closure of VDAC using Koenig's polyanion, phosphorothioates,
or the anion channel blocker DIDS, actually enhances the MPT re-
sponse in isolated mitochondria [23,30,31].
3. VDAC and apoptosis
While evidence for a role of VDAC in outermitochondrialmembrane
permeabilization and apoptosis persistently accumulates, the mecha-
nisms behind VDAC's role remain very poorly understood. In fact, it is
still debated whether VDAC opening, or closure results in apoptosis
[6]. The existing evidence of how VDAC is involved in outer membrane
permeability and release of cytochrome c can be grouped into roughly
three models: model #1) VDAC is part of the MPTP complex and pro-
apoptotic agents therefore induce cytochrome c release indirectly
through activation of the MPTP, model #2) VDAC homo- or hetero-
oligomerization creating a larger pore capable of releasing cytochrome
c, and model #3) VDAC closure resulting in a build up of mitochondrial
metabolites, mitochondrial swelling, and either outer membrane per-
meabilization through an speciﬁc undeﬁned mechanism or generalized
rupture (Fig. 1). In the “VDAC and the mitochondrial permeability
transition pore (MPTP)” section, we have already discussed the evi-
dence that largely discredits model #1. We will next discuss the evi-
dence both for and against models #2 and #3 of VDAC-mediated
outer membrane permeabilization.
3.1. Model #2 — VDAC homo- or hetero-oligomerization leading to outer
mitochondrial membrane permeabilization
Studies in several cell types overexpressing human, murine, yeast,
Paralichthys olivaceus, or rice VDAC have observed increased
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Fig. 1. Proposed models for VDAC's role in outer mitochondrial membrane permeabilization and induction of apoptosis. In model #1, the VDAC is a component of the MPTP and
therefore causes cytochrome c release indirectly through the swelling and rupture of mitochondria. This model has largely been discredited, as mitochondria lacking VDACs still
possess a normal MPT response. Model #2 involves either homo-oligomerization of VDAC channels or hetero-oligomerization with VDAC and Bax/Bak to produce a large channel
capable of releasing cytochrome c. However, this model is also highly questionable as cells devoid of all VDACs actually exhibit enhanced cell death in response to apoptotic stimuli,
thus suggesting that VDAC plays a protective role against cell death. Evidence of VDAC's interaction with Bax or Bak is limited and has also been questioned. Model #3 details how
anti-apoptotic agents modulate VDAC to keep it in the open state, maintaining adenine nucleotide ﬂux, thus maintaining outer membrane permeability. On the other hand, a grow-
ing list of pro-apoptotic modulators of VDAC has been shown to close VDAC, inhibiting adenine nucleotide ﬂux, causing mitochondrial permeability and cell death. This model #3
thus ﬁts with concept of a functional VDAC channel being cytoprotective.
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species (ROS) production leads to the increase in cell death observed
with VDAC overexpression [37,38], however, the mechanisms have
not been thoroughly investigated. A recent report tested the viability
of yeast cells transfected with the three human VDAC isoforms indi-
vidually [39]. Interestingly, cells that expressed VDAC1 and VDAC2
showed similar levels of ROS and similar viability to wildtype yeast.
However, yeast transformed with VDAC3 had higher levels of ROS
and decreased viability (increased death) [39]. In contrast, we have
shown that murine ﬁbroblasts essentially devoid of all three VDAC
isoforms are actually more sensitive to staurosporine-, and TNFα-
induced death [28], suggesting that VDAC may actually play an anti-
apoptotic, rather than pro-apoptotic, role.
One explanation for VDAC overexpression leading to increased cell
death is that higher VDAC expression favors VDAC oligomerization
(Fig. 1, model #2). Indeed, arrays of VDAC in plant outermitochondrial
membranes were very early observations [40]. It has been suggested
that oligomeric VDAC1 mediates the release of cytochrome c [41],
since the internal diameter of a single VDAC pore is 2.5–3.0 nm,
which is insufﬁcient to pass a folded protein. VDAC1 has been shown
to assemble into dimers, trimers, tetramers, and multimers [41–46].
Interestingly, overexpression of the anti-apoptotic protein Bcl-xL has
been shown to prevent VDAC homo-dimerization [19].VDAC has also been suggested to assemble into hetero-oligomers
with pro- and anti-apoptotic Bcl-2 proteins. There are two models
of VDAC associating with Bcl-2 family proteins (Fig. 1). The ﬁrst model
involving Bcl-2 proteins (model #2) entails pro-apoptotic Bax binding
to VDAC, creating a large VDAC–Bax channel, and causing cytochrome
c release [18,26,47–49]. Model #2 concludes that, although the chan-
nels formed by Bax or VDAC alone are unable to translocate cytochrome
c, the new larger Bax–VDAC channel is permeable to cytochrome c [47].
In complete disagreementwith this model, mammalian VDAC reconsti-
tuted into planar phospholipid membranes has shown Bax to not have
any effect on the properties of VDAC channels [50]. While monomeric
Bax is found in the cytosol of healthy cells [51,52], tBid triggers Bax
oligomerization [53,54] causing Bax to form channels in the outer
membrane that allow for cytochrome c release [55,56]. Neither the
monomeric nor oligomeric form of Bax showed any interaction
with VDAC channels [50]. Additionally, immunoprecipitations have
failed to detect Bax–VDAC interaction [57], and the levels of Bax
required for killing in VDAC1−/− yeast cells were similar to wild-type
cells [58].
The VDAC2 isoform has been shown to bind the pro-apoptotic
Bak, however, its role is still controversial. The ﬁrst report by
Cheng et al. [59] suggested that VDAC2, but not VDAC1, binds inac-
tive Bak in normal healthy cells. Treatment with tBid released Bak
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VDAC2−/− cells had greater activation (oligomerization) of Bak,
and increased sensitivity to apoptotic stimuli [59]. Bax was not
shown to make complexes with VDAC2 even in apoptotic situations,
which argues against model #2. Interestingly, in Bax-deﬁcient cells,
the VDAC2–Bak interaction is no longer observed with or without
apoptotic stimulation [60]. A more recent study showed that
VDAC2 is required for the formation of the inactive Bak complex,
and that the Bak transmembrane anchor is required for interacting
with VDAC2 [61]. Furthermore, another study suggests that VDAC2
is required for tBid-induced Bak activation and apoptosis [62]. This
study showed that although VDAC1−/−, VDAC3−/−, and VDAC1/
3−/− ﬁbroblasts respond normally to tBid, VDAC2−/− ﬁbroblasts
are virtually insensitive to tBid-induced outer membrane permeabi-
lization and apoptosis [62]. Additionally, VDAC2 may be required for
Bax-induced outer membrane permeability and apoptosis in Bak−/−
cells [63]. Thus, these studies suggest that VDAC2 interacts with Bak
and mediates Bak-activated apoptosis in a Bax- and tBid-dependent
manner [60,62,64].
3.2. Model #3— proteins and metabolites alter VDAC conductance, resulting
in outer membrane permeabilization through unknown mechanisms
In a new model (Fig. 1, model #3), tBid was shown to induce
VDAC closure, reducing adenine nucleotide exchange between mito-
chondria and cytosol, thus creating mitochondrial dysfunction [50].
Conversely, but also along the lines of model #3, the anti-apoptotic
Bcl-xL has been shown to bind VDAC [44] and promote its open con-
ﬁguration and maintain ATP/ADP exchange [65]. Thus, model #3 de-
scribes how proteins and metabolites modulate VDAC conductance.
VDAC closure prevents the exchange of ATP/ADP and all other larger
respiratory metabolites, which then leads to outer membrane permea-
bilization and release of proteins from the intermembrane space
[65,66]. It is unknown how the permeabilization occurs, either through
undeﬁned pathways or via swelling and rupture of the outer mem-
brane. It is also not known how or if tBid and VDAC physically interact.
Although the mechanism(s) are unclear, it is apparent that VDACs
modulate outer membrane permeability and therefore the release
of intermembrane proteins and apoptosis. The next section of this
review will detail several metabolites and non-Bcl-2 family proteins
that have been shown to modulate VDAC permeability.
4. Regulators of VDAC permeability and their role in cell death
To date, a number of metabolites and proteins have been shown to
bind and modulate VDAC conductance. However, the effects of al-
tered VDAC permeability on cell death are still unclear. While ATP/
ADP [67,68], glutamate [69], ROS [70], the 18 kDa translocator protein
[71], and hexokinase [72] have all been suggested to modulate MPT, it
is easy to propose that these agents are working through VDAC to af-
fect MPT (model #1). However, as VDACs are dispensable for MPT
[28,29], these agents must be working through another mechanism,
perhaps by altering VDAC structure and preventing Bcl-2 protein
interaction (model #2) or by altering VDAC conductance and creating
outer mitochondrial membrane permeability through an unknown
mechanismor outermembrane rupture (model #3) as discussed above.
4.1. Adenine nucleotides
As the main purpose of VDAC is to shuttle adenine nucleotides
between themitochondria and cytosol, it onlymakes sense that adenine
nucleotides can modulate VDAC behavior. The discovery of at least two
nucleotide-binding sites on VDAC [73–75] explains how NAD(P)H, ATP,
and ADP can decrease VDAC channel conductance [3,76]. Indeed, ATP
bound to the nucleotide-binding site on VDAC is suggested to sterically
block VDAC [3,76]. Mechanistically, this interaction of VDAC with ATP/ADP and NAD(P)H explains how energetic pathway intermediates can
modulate outer mitochondrial membrane permeability and respiration
rates to adjust to cellular energy requirements.
The effect of adenine nucleotides on mitochondrial permeability
(and subsequent cell death) has been thoroughly studied. Yehezkel et
al. [75] showed that T-Rex-293 cells expressing VDAC1with amutation
in the nucleotide-binding site had severely diminished ATP synthesis
and ATP levels. NAD(P)H, ADP, and particularly ATP inhibit the MPTP
[67]. During ischemia, ATP and ADP are degraded to nucleosides and
bases, and thus the inhibition of the MPTP is lost. Therefore, ischemia
or other noxious stimuli that decrease the exchange of adenine nucleo-
tides through VDAC can cause MPT and subsequently, cell death. Thus,
excess adenine nucleotides may decrease VDAC conductance, and
cause outer membrane permeabilization, resulting in cell death, which
ﬁts model #3 (Fig. 1).
4.2. Glutamate
Much of a cell's glutamate is formed in the mitochondria through
the action of glutamate dehydrogenase on the TCA cycle intermediate
α-ketoglutarate. The glutamate formed in the mitochondria can then
be exported to the cytosol, crossing the outer membrane through
VDAC. Studies suggest that VDAC contains a glutamate-binding site,
as L-glutamate has been shown to cause VDAC to oscillate between
the stable (more closed) and open conformations decreasing Ca2+ trans-
port [69,77,78]. The decreased Ca2+ import caused by L-glutamate has
been shown to inhibit MPTP opening, decrease mitochondrial swelling,
as well as decrease cytochrome c release from mitochondria [69]. Thus,
it appears that glutamate is protective against cell death by inhibitingmi-
tochondrial Ca2+ import through VDAC. The decreased VDAC conduc-
tance caused by glutamate clearly ﬁts with model #3 in that decreased
VDAC conductance can result in outer membrane permeabilization.
4.3. Tubulin
Tubulin, the heterodimeric subunit of microtubules has been
shown to bind mitochondria via VDAC [79,80]. Dimeric tubulin closes
VDAC channels reconstituted into planar phospholipid membranes
[81]. Tubulin decreased outer mitochondrial membrane permeability
to adenine nucleotides in isolated brain mitochondria and permeabi-
lized cardiomyocytes [81,82]. Recently, the microtubule destabilizing
compounds rotenone, colchicine, and nocodazole were shown to in-
crease free tubulin and decrease the mitochondrial membrane poten-
tial; conversely, the microtubule stabilizer paclitaxel decreased free
tubulin and hyperpolarized mitochondria of HepG2 cells (cancerous
hepatoma cells) and primary rat hepatocytes [83]. Thus, free tubulin
can decrease VDAC conductance and ultimately lead to outer mito-
chondrial membrane permeabilization and cell death, which ﬁts
model #3. This inhibition of VDAC by free tubulin limits mitochondri-
al respiration, and may explain the Warburg effect in cancer cells,
which by nature require excess tubulin to support rapid division.
Only time will tell if this interaction can be utilized to control cancer
cell death in vivo.
4.4. Reactive oxygen species
Mitochondrially produced ROS has been shown to be involved in
cell death, and Ca2+ accumulation by mitochondria is associated
with mitochondrial ROS generation by mechanism(s) that are poorly
understood [84,85]. Several studies suggest that VDAC plays a role
in this mechanism. Mitochondrial-generated ROS has been shown to
induce cytochrome c release, which is inhibited by VDAC blockers
or anti-VDAC antibody [70,86]. Interestingly, the same effect is not
seen with the MPTP inhibitor cyclosporine A [86]. ROS caused cardio-
lipin peroxidation, which was interpreted as the means by which
cytochrome c was released from its cardiolipin-mediated attachment
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chrome c is released and the role of VDAC in its release remains un-
known. As discussed earlier, cytochrome c is too large to be released
through monomeric VDAC. Possible mechanisms include oligomeric
VDAC forming a larger channel [41] (model #2), or that mitochondrial
membrane lipid peroxidation impairs membrane function and alters
VDAC properties, resulting in outer mitochondrial membrane permea-
bilization (model #3). Indeed, the gating properties of VDAC channels
reconstituted into lipid bilayerswere signiﬁcantly affected by lipid com-
position [87].
4.5. Peripheral benzodiazepine receptor (PBR) or 18 kDa translocator
protein (TSPO)
The peripheral benzodiazepine receptor (PBR), now known as the
18 kDa translocator protein (TSPO), is expressed on the outer mito-
chondrial membrane and mediates cholesterol import into the mito-
chondria for steroidogenesis [88]. TSPO interacts with VDAC on the
outer membrane, and may alter its properties [89]. Importantly, the
TSPO has been implicated in ROS production in models of neurode-
generation and cancer [90,91]. The proapoptotic agent erucylphos-
phohomocholine (ErPC3) was shown to increase ROS generation
and cause oxidation of cardiolipin on the inner mitochondrial mem-
brane, while the TSPO ligand PK11195 prevented this ROS generation
and induction of apoptosis [71]. Interestingly, electron microscopy
studies have found large groupings of the TSPO around VDAC chan-
nels [92], potentially increasing ROS concentrations in the proximity
of VDAC. Therefore, the 18 kDa TSPO likely affects VDAC conductance
by production of ROS, causing outer membrane permeabilization
(model #3).
4.6. Hexokinases
Perhaps themost studied regulator of VDAC function is the glycolytic
enzyme hexokinase. A 21-amino-acid sequence in the N-termini of
hexokinase isoforms 1 (HK1) and 2 (HK2) is predicted to form a hydro-
phobicα-helix, which is essential and sufﬁcient for binding tomitochon-
dria [93,94]. Interaction with VDAC is believed to cause the speciﬁcity of
hexokinases binding to the outer mitochondrial membrane [95,96].
Binding of HK2 to isolated mitochondria or overexpression of HK2 in
HeLa cells has been shown to inhibit the mitochondrial translocation of
Bax and the release of cytochrome c [97]. Majewski et al. [98] conﬁrmed
that mitochondrial HK inhibits cytochrome c release and apoptosis;
however, this was also true in Bax- and Bak-deﬁcient cells. This study
suggested that mitochondrial hexokinase prevented VDAC closure.
Thus, this study is in agreement with Vander Heiden et al. [65,66] in
that VDAC closure (due toHK detachment) leads tomitochondrial swell-
ing and consequently to cell death via an undeﬁnedpathway. HKbinding
and inhibiting closure of VDAC therefore ﬁts into model #3 and explains
how mitochondrial-bound HK protects against outer mitochondrial
membrane permeabilization and cell death.
Conversely, a direct inhibitory effect of HK1 has been reported on
VDAC channels reconstituted into planar membranes [72]. This study
showed that HK1 induced VDAC closure, and that addition of hexoki-
nase's reaction product glucose-6-phosphate released HK from VDAC
and allowed VDAC reopening [72]. These authors suggest that HK1-
induced closure of VDAC inhibits MPTP opening, which is not in
agreement with VDACs being inessential for MPT [28,29]. Biochemi-
cally, HK1-mediated closure of VDAC does not make sense, as VDAC
closure would inhibit nucleotide exchange and hinder the ATP supply
by which HK1 depends on for its enzymatic activity. In support of this
notion, hexokinases preferentially utilize intramitochondrially gener-
ated ATP from oxidative phosphorylation [99]. In fact, in most cells,
mitochondrial respiration increases dramatically after addition of glu-
cose, a phenomenon termed the Pasteur effect [100]. Therefore, HK1-
mediated closure of VDAC causing decreased MPT argues against notonly the biochemical activity of HK, but also does not ﬁt with model #3.
While this ﬁnding should be highly scrutinized, it does imply that the
mechanism of how HK protects against cell death and what role, if any,
VDAC plays in this mechanism still remains to be deﬁnitely described.
5. Questions raised by genetic models of VDAC
deﬁciency/overexpression
One conundrum raised by the genetic ablation of VDAC isoforms,
is how do mitochondria devoid of VDAC still function metabolically,
and perhaps more importantly, what has changed? The same argu-
ment can be made for overexpression of VDAC isoforms. Certainly
cells lacking essentially all 3 VDAC isoforms still seem to exist in cul-
ture relatively easily, although, as mentioned above and later on, they
are more susceptible to death stimuli than their wildtype counter-
parts [6]. It is conceivable that other outer membrane anion channels
such as the peripheral benzodiazepine receptor could compensate
electrically and/or metabolically for the loss of VDACs, indicating
that adaptations occur that could also inﬂuence cell death end-
points. However, VDAC1−/− cells have enlarged mitochondria
[6,101], and VDAC1−/− and VDAC1/VDAC3−/− muscle mitochondria
have substantially less HK activity [102], suggesting that substantial
mitochondrial alterations can occur. Thus, the question that arises is
this: are the effects (or lack thereof in the case of the MPTP) of
VDAC depletion indicative of a primary role for VDAC in that process,
or are they due to secondary changes in mitochondrial structure and/
or function caused by the general impairment of metabolite transport
across the outer membrane? Can these even be separated? For exam-
ple, model #3 suggests that the role of VDAC in modulating cell death
is entirely due to its ability to greatly inﬂuence metabolite ﬂux across
the outer membrane.
Another question that is raised is the concept of redundant versus
non-redundant functions of each VDAC isoform. For the most part,
one mammalian VDAC seems to be able to compensate for the lack
of another [103]. This of course brings up the issue of a negative phe-
notype simply being due to redundancy, and that is certainly why we,
and others, attempt to ablate all 3 VDAC isoforms in a cell at a given
time. However, it is becoming more apparent that there are some
functional differences between isoforms especially with regard to
tissue-speciﬁcity. For instance, VDAC1 deletion affects mitochondrial
respiration similarly in both heart and skeletal muscles, whereas
VDAC3 ablation primarily only affects the mixed glycolytic/oxidative
skeletal muscle [101,104]. The relative expression of each VDAC iso-
form also differs between tissues [105], which in turn could also inﬂu-
ence mitochondrial function and, ultimately, cell death progression in
a tissue-speciﬁc manner.
These are all issues that need to be considered when using any
genetic model, but especially when there are several isoforms involved,
both with regard to the designing and interpretation of experiments.
The reﬁnement of genetic approaches (tissue-speciﬁcity, temporal in-
duction, reconstitution of selective isoforms etc.) should hopefully help
address these issues.
6. Conclusions
Although VDAC undoubtedly plays a role in outer mitochondrial
membrane permeabilization and induction of cell death, the mecha-
nisms remain poorly understood. As we have discussed, VDAC on its
own cannot induce apoptosis. The diameter of the VDAC pore cannot
be drastically increased to allow passage of proapoptotic proteins.
Likewise, while VDAC overexpression may increase VDAC homo-
oligomerization, we have shown that mitochondria devoid of all
VDACs have an increased MPT response, portraying not a pro-death
role, but rather a pro-survival role for VDAC. Lastly, modulation of
VDAC by cytosolic mediators is the most deﬁnitive mechanism for
causing outer membrane permeabilization. Future research is needed
1449K.S. McCommis, C.P. Baines / Biochimica et Biophysica Acta 1818 (2012) 1444–1450to further characterize the mechanisms of these VDAC-modulating
agents.
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